Cathy Smith’s “wide bandwidth of experience could serve the company well,” a William Blair analyst noted, “despite her lack ...

Equities researchers at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Intellia ...

Stock analysts at William Blair boosted their Q4 2025 EPS estimates for shares of Global Industrial in a research report ...

We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...

William Blair International Leaders Fund earns an Average Process Pillar rating. The leading factor in the rating is the stability of the management team. Specifically, the fund has not seen a ...

William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from low expenses across its parent firm's funds, whose fees rank in their respective ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Nektar Therapeutics (NKTR – Research Report). The ...

In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Altimmune (ALT – Research Report). The company’s shares ...

The investment firm that helped Bally's take control of its future Chicago casino site is subleasing a floor in a riverfront tower from William Blair. Edgar Jannotta, chairman emeritus of ...

The Fund seeks long-term capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of equity securities, including common ...